Received Aug 6, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| RSV | RSV (AREXVY) | GLAXOSMITHKLINE BIOLOGICALS | 1 | 29Z7E | — |
Vaccine expired on 1 July 2025, and 19 days later the vaccine was administered to a patient; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of expired vaccine used in a 82-year-old female patient who received RSVPreF3 adjuvanted (Arexvy) (batch number 29Z7E, expiry date 01-JUL-2025) for prophylaxis. On 20-JUL-2025, the patient received the 1st dose of Arexvy. On 20-JUL-2025, an unknown time after receiving Arexvy, the patient experienced expired vaccine used (Verbatim: Vaccine expired on 1 July 2025, and 19 days later the vaccine was administered to a patient). The outcome of the expired vaccine used was not applicable. Additional Information: GSK Receipt Date: 30-JUL-2025 The pharmacist reported that the maladministration of an expired dose of Arexvy., which led to expired vaccine used The vaccine expired on 1st July 2025, and 19 days later the vaccine was administered to a patient someone called to ask was it needed to revaccinate the patient The pharmacist confirmed the vaccine was administered in other place and she only got the call asking for some guidance.